CN1680433A - Recombinant N protein antigen and purification for transmissible gastroenteritis of swine - Google Patents

Recombinant N protein antigen and purification for transmissible gastroenteritis of swine Download PDF

Info

Publication number
CN1680433A
CN1680433A CN 200510009706 CN200510009706A CN1680433A CN 1680433 A CN1680433 A CN 1680433A CN 200510009706 CN200510009706 CN 200510009706 CN 200510009706 A CN200510009706 A CN 200510009706A CN 1680433 A CN1680433 A CN 1680433A
Authority
CN
China
Prior art keywords
gene
tgev
recombinant
protein
protein antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200510009706
Other languages
Chinese (zh)
Other versions
CN1285609C (en
Inventor
李一经
唐丽杰
师东方
马广鹏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northeast Agricultural University
Original Assignee
Northeast Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northeast Agricultural University filed Critical Northeast Agricultural University
Priority to CN 200510009706 priority Critical patent/CN1285609C/en
Publication of CN1680433A publication Critical patent/CN1680433A/en
Application granted granted Critical
Publication of CN1285609C publication Critical patent/CN1285609C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Porcine transmissible gastroenteritis recombinant N protein antigen and its purification are disclosed. It is carried out by extracting viral nucleic acid by purified TGEV virus liquid, virogenic group cDNA synthesizing by upstream primer Li01 of TGEV N gene, using upstream and downstream primer of TGEV N gene, N gene amplifying, cloning the amplified TGEV N gene in prokaryotic expressing carrier plasmid pProEXHTb, expressing in strain of colibacillus, and obtaining porcine transmissible gastroenteritis recombinant N protein antigen. It can overcome potential risk of toxin ejection and be used for diagnostic antigen of disease monitor.

Description

Swine infectious enterogastritis recombinant N protein antigen and purification process
(1) technical field
What the present invention relates to is a kind of biotechnological formulation, the invention still further relates to the preparation method of this biotechnological formulation.Specifically a kind of swine infectious enterogastritis recombinant N protein antigen and preparation method.
(2) background technology
Transmissible gastroenteritis of swine is that (clinical symptom is serious diarrhoea, vomiting and dehydration for Transmissiblegastroenteritis virus, a kind of acute, the height contagious disease of the pig that TGEV) causes by transmissible gastro-enteritis virus.The equal susceptible of the pig of different ages and kind, especially with 2 the week ages with interior piglet case fatality rate up to 100%.
The traditional diagnosis method of transmissible gastroenteritis of swine is often according to epidemiology and the clinical manifestation foundation as tentative diagnosis.But owing to rotavirus and the Porcine epidemic diarrhea virus of pig also can cause similar disease, and on epidemiology and symptom, be difficult to difference, therefore must rely on virus separation and serology experiment to make a definite diagnosis at last.
Since nineteen forty-six Doyle and Hutchings reported first transmissible gastroenteritis of swine, big quantity research has been carried out to the TGEV diagnostic techniques in countries in the world, has set up viral separation (Isolation of Virus IV), fluorescent-antibody technique (Fluorescent Antibody TestFAT), immune electron microscopy (Immune electron microscopy IEM), virus neutralization tests (Virus Neutralization VN), enzyme linked immunosorbent assay (enzyme-linked immunosorbent assay ELISA), nucleic acid probe (Nucleic acidprod) and polymerase chain reaction methods such as (Poly Chain Reaction PCR).Can carry out tentative diagnosis to TGE according to epidemiology, clinical symptom and pathological change,, also need the laboratory to make a definite diagnosis if distinguish mutually with the intestinal tract disease that porcine rotavirus (PRV) and Porcine epidemic diarrhea virus (PEDV) cause.
Eqpidemic disease diagnosis fast and accurately is the important prerequisite of control transmissible gastroenteritis of swine.And China does not also have the effective prevention and treatment method of a cover at present.In clinical diagnosis to suspicious pathological material of disease carry out virus separate with evaluation be this disease diagnostic method the most intuitively, but isolated viral needs certain condition and considerable time, the drawback that therefore, that this diagnostic method exists is time-consuming, effort again can not quick diagnosis; This sick fast diagnosis method the most normal application be serological test, as neutralization test, fluorescent antibody test and enzyme linked immunosorbent assay etc.And the accuracy of serological method diagnosis depends on the specificity of diagnostic antigen and antibody.
(3) summary of the invention
The object of the present invention is to provide a kind ofly can overcome the existing toxin expelling of antigen in the transmissible gastroenteritis of swine traditional diagnosis method, the potentially dangerous of the poison that looses, can be used as a kind of swine infectious enterogastritis recombinant N protein antigen of diagnostic antigen of disease surveillance; The present invention also aims to provide a kind of
The antigenic purification process of swine infectious enterogastritis recombinant N protein.
The object of the present invention is achieved like this: it is to carry out viral nucleic acid (RNA) the TGEV virus liquid behind purifying to extract, upstream primer Li01 with TGEV N gene carries out the synthetic of viral genome cDNA, re-use TGEV N gene on, downstream primer, carry out the amplification of N gene, with the amplification after TGEV N gene clone in prokaryotic expression carrier plasmid pProEXHTb, and in e.colistraindh5, express and obtain swine infectious enterogastritis recombinant N protein antigen, its called after Escherichia coli DH5 a with recombinant plasmid of transmissiblegastroenteritis virus necleoprotein gene.
The upstream and downstream primer sequence is respectively:
Li01?5’AAC?TTC?GAA?ATG?GCC?AAC?C?3’ 19-mer;
Li02?5’AGC?TCG?AGC?ATC?TCG?TTT?AG?3’ 20-mer。
Swine infectious enterogastritis recombinant N protein of the present invention is to adopt such method purifying:
The great expression of 1 fusion rotein
(1) e.colistraindh5 of inoculating expressed fusion protein sways overnight incubation in 10ml LB/ penbritin liquid nutrient medium in 37 ℃;
(2) transfer the 10ml overnight culture in 500ml LB/ penbritin liquid nutrient medium, sway in 37 ℃ and be cultured to OD 590Value reaches about 0.5, takes out 1ml sample power supply swimming and analyzes;
(3) add 0.5ml 1mol/L IPTG to final concentration be 0.6mmol/L, continue to be cultured to OD value in 37 ℃ and reach 1.0, stop cultivating, take out 1ml sample power supply swimming analysis.
The purifying of 2 fusion roteins
(1) in 1.5cm * 7.5cm chromatography column, adds 1mlNi 2+-NTA gel media behind the 20ml deionization washing post, is washed post with 20ml Buffer A solution again;
(2) with bacterium liquid through the centrifugal 20min of 10 000g/min, remove supernatant, sedimentary thalline carries out the cracking thalline with BufferA solution 10ml, dissolution precipitation, behind the stirring at room 1h, 4 ℃ continue to be stirred and to spend the night;
(3) solute is moved in the 30ml centrifuge tube, under 4 ℃ of conditions,, get supernatant and wait until upper prop usefulness with the centrifugal 40min of 20 000g/min;
(4) flow velocity of supernatant with 0.5ml/min joined in the Ni-NTA post; Collect effluent liquid, carry out SDS-PAGE and analyze;
(5) use 20ml Buffer A, the 20ml Buffer B flow velocity washing with 0.5ml/min successively, and collect effluent liquid, SDS-PAGE analyzes;
(6) wash with the Buffer C 10ml that contains the 80mmol/L imidazoles, collect elutriant, under the ultraviolet wavelength of 280nm, detect proteic absorption peak, preservation contains the elutriant of recombinant protein, and the storage temperature that short-term is preserved is 4 ℃, and the storage temperature of prolonged preservation is-20 ℃.
Along with the development and use of modern techniquies such as modern molecular immunology and molecular biology, for new way has been opened up in the development of biotechnology diagnostic reagent of new generation.Diagnostic antigen or antibody with advanced technique means acquisition such as genetically engineered, cell engineering, its outstanding feature is that homogeneity is good, the purity height, high specificity, stable performance, and be easy to preserve and produce in batches, diagnostor of Jian Liing and method are easy to International standardization thus, are the main directions of the development of eqpidemic disease diagnosis from now on.Simultaneously, with the diagnostic antigen that biotechnology is produced, can avoid loaded down with trivial details cell cultures to prepare a large amount of antigenic substances, this is to difficult viral extremely useful of breeding on cell.
TGEV N albumen is very conservative phosphorylated protein, and molecular mass is 47ku, be a kind of dominance structure albumen of TGEV, and can excite stronger immunne response, therefore to nucleocapsid (N) gene of TGEV clone, expression and expression product purifying thereof.No matter the nucleoprotein product of its purifying is the diagnostic antigen as a kind of disease surveillance, and still the immunological reagent of replying as a kind of excitating organism all is extremely useful novel biological agents.The further application of said preparation will provide important basic substance to the diagnosis and treatment of TGE.The diagnosis of TGE the control this disease popular on have vital role, therefore further improve these detection methods, make it to have specificity, the susceptibility of height, quicker, easy, more be applicable to the detection of conventional a large amount of samples, will have prior practical significance.
Utilize the reorganization TGEV N albumen of Protocols in Molecular Biology preparation to have the immunobiology characteristic close with natural N albumen; and can large-scale production; this technology has been avoided adopting vitro culture totivirus antigen, differential centrifugation and density gradient centrifugation purified virus, has been handled the proteic loaded down with trivial details antigen production method of exposure virus N with biochemical reagents; improve working efficiency, reduced nonspecific reaction.With the antigen that this method is produced, can avoid disseminating as antigen the danger of virus with live virus.
(4) description of drawings
Fig. 1 is the RT-PCR result of TGEV nucleoprotein gene, wherein:
1.DNA?Ladder
2-3. nucleoprotein gene PCR product
4.PCR contrast
5.DNA?Marker?DL15000
Fig. 2 is that the enzyme of TGEV N gene is cut qualification result, wherein:
1.DNA?Ladder?100bp
2.N gene is cut with Xba I enzyme
3.N gene is cut with Pst I enzyme
4.N gene is cut with the HindIII enzyme
Fig. 3 is that the enzyme of recombinant plasmid PHN is cut the product electrophoretogram, wherein:
1.DNA?Marker?DL15,000
2. vector plasmid pProEXHTb
3.XhoI single endonuclease digestion vector plasmid
4. recombinant plasmid PHN
5.XhoI single endonuclease digestion recombinant plasmid PHN
6.XhoI, NspV double digestion recombinant plasmid PHN
Fig. 4 be TGEV N gene at the SDS-PAGE of escherichia coli expression electrophoretogram, wherein:
1. standard protein molecular weight 20~90ku
2. the cellular lysate thing that contains plasmid pProEXHTb without the IPTG inductive
3. the cellular lysate thing that contains plasmid pProEXHTb through the IPTG inductive
4. the cellular lysate thing that contains recombinant plasmid PHN without the IPTG inductive
5. the cellular lysate thing that contains recombinant plasmid PHN through the IPTG inductive
Fig. 5 is the proteic Western blot of an expression in escherichia coli N collection of illustrative plates, wherein:
1, the cellular lysate thing that contains plasmid pProEXHTb without the IPTG inductive
2, the cellular lysate thing that contains plasmid pProEXHTb through the IPTG inductive
3, the cellular lysate thing that contains recombinant plasmid PHN without the IPTG inductive
4, the cellular lysate thing that contains recombinant plasmid PHN through the IPTG inductive
Fig. 6 is the electrophoretogram of fusion rotein purifying, wherein:
1, standard protein molecular weight 20~90ku
2, without IPTG inductive tropina
3, through IPTG inductive tropina
4, through buffer A cracked IPTG inductive tropina
5, through the tropina of affinitive layer purification
Fig. 7 is the fusion rotein Western-blot collection of illustrative plates behind the purifying
Fig. 8 is expression efficiency distribution of results figure
Fig. 9 is the data results table of expressing fusion protein efficiency analysis.
(5) specific embodiments
Carrying out viral nucleic acid (RNA) the TGEV virus liquid behind purifying extracts, upstream primer Li01 with TGEV N gene carries out the synthetic of viral genome cDNA, re-use TGEV N gene on, downstream primer, carry out the amplification of N gene, with the amplification after TGEV N gene clone in prokaryotic expression carrier plasmid pProEXHTb, and in e.colistraindh5, express, characteristics according to carrier, this experiment selects for use IPTG to induce Expression of Fusion Protein, expression product is after SDS-PAGE analysis and the immune marking (Western-blot) detection antigenic activity, 6 continuous histidine residues that the purifying of fusion rotein utilizes the expressed recombinant protein of prokaryotic expression carrier pProEXHT to have, can be combined on the Ni-NTA post, can be combined in Ni because of imidazoles again with competing 2+On-NTA the post and recombinant protein is replaced, for the extraction purifying of recombination fusion protein provides a kind of effective ways.
The concrete making method of product of the present invention is:
The extraction of TGEV TH-98 pnca gene group RNA
Proteinase K, 10%SDS cracking, add each extracting of isopyknic phenol/chloroform and chloroform once, the dehydrated alcohol precipitate nucleic acids of 2mol/L sodium acetate and 2.5 times of volumes, with 70% cold washing with alcohol precipitation, after the drying at room temperature, add an amount of (about 12 μ l) aseptic deionized water dissolving nucleic acid precipitation ,-20C preserves standby.
The synthetic the primer of RT: viral genome cDNA is the upstream primer Li01 of TGEV N gene, and reaction system and condition are undertaken by the specification sheets of ThermoScript II.The upstream and downstream primer of TGEV N gene is used in the amplification of PCR:TGEV N gene, carries out according to the specification sheets of Taq archaeal dna polymerase.
↓ RT-PCR amplification N gene and purifying
↓ XhoI, NspV double digestion N gene and vector plasmid pPRoEXHTb and purifying (purifying adopts DNA a small amount of purification kit to carry out)
Ligation is undertaken by the specification sheets of T4 dna ligase, and adds PEG 8000 to increase binding efficient; The frightened method of heat is transformed into host bacterium DH5 α.
↓ connect and be transformed into the host bacterium
Primer sequence is as follows: Li01 5 ' AAC TTC GAA ATG GCC AAC C 3 ' 19-mer; Li02 5 ' AGC TCG AGC ATC TCG TTT AG 3 ' 20-mer.
↓ positive plasmid is identified (enzyme is cut and sequencing)
↓ protein expression (IPTG induces)
The extraction of plasmid is carried out with a small amount of plasmid extraction kit; Restriction enzyme XhoI and NspV carry out single endonuclease digestion and double digestion to the extraction plasmid respectively, and the product after enzyme is cut carries out check and analysis through 0.8% agarose gel electrophoresis.
SDS-PAGE and Western-blot test
↓ fusion rotein purifying
↓ Western-blot analyzes
Fig. 1 is the RT-PCR result of TGEV nucleoprotein gene, uses the RT-PCR method, and cDNA is a template with reverse transcription synthetic TGEV TH-98 strain, goes out the fragment of about 1200bp with designed primer amplification, and the amplified production size conforms to desired design (1174bp).
Fig. 2 is that the enzyme of TGEV N gene is cut qualification result, select for use restriction enzyme HindIII, Pst I, Xba I on the N gene restriction enzyme mapping that the PCR product is carried out restriction analysis, the result has obtained about 500bp and 600bp, about 350bp and 700bp and about 450bp and 700bp fragment respectively, and it is consistent with expected results that enzyme is cut qualification result.
Fig. 3 is that the enzyme of recombinant plasmid PHN is cut the product electrophoretogram, and recombinant plasmid with XhoI single endonuclease digestion and XhoI and NspV double digestion, has been obtained respectively and the fragment of estimating that size conforms to.I.e. two fragments that obtain with XhoI and the NspV double digestion 4780bp fragment that is the pProEXHTb vector plasmid and the 1174bp fragment of goal gene, and with the XhoI single endonuclease digestion clip size be sum of the two, about promptly about 6000bp.Show the recombinant plasmid that has obtained the TGEV nucleoprotein gene.
Fig. 4 be TGEV N gene at the SDS-PAGE of escherichia coli expression electrophoretogram, the result shows that reorganization cellular lysate thing produces a special protein band between 66ku and 43ku, and expects the big or small consistent of albumen (47ku).But not in the pProEXHTb plasmid bacterium culture samples of reorganization, then do not have this and take out of existing.Other is non-obvious band of expression all not occur through IPTG inductive plasmid bacterium.
Fig. 5 is a Western blot collection of illustrative plates, the DH5 α cellular lysate thing that contains recombinant plasmid PHN, after SDS-PAGE and electric transfer printing, the 47ku recombinant protein of expression can with TGEV antiserum(antisera) generation specific reaction, show the reorganization nucleoprotein have and the same antigen-specific of natural TGEV N albumen.
Fig. 6 is the electrophoretogram of fusion rotein purifying, can find out from electrophoretogram, uses this purification process finally to obtain the higher fusion rotein of purity.
Fig. 7 is the fusion rotein Western-blot collection of illustrative plates behind the purifying, and from figure as can be seen, the fusion rotein behind the purifying carries out the western-blot detection and still keeps its antigen-specific.
Fig. 8 is expression efficiency distribution of results figure, and wherein r7 is a recombinant N protein, and molecular weight is 47ku (shown in chart 9 arrows), and its content accounts for 20.409% of bacterial protein, and the result shows that fusion rotein has obtained to efficiently express in intestinal bacteria.
Sequence table
Figure A20051000970600101
GCCAACCAGGGACAGCGTATTAGTTGGGGGGATGAATCTACCAAAACACGTGG
TCGTTCCAATTCCCGTGGTCGGAAGAATAATAACATACCTCTTTCATTCTTCAACCCC
ATAACCCTCCAACAAGGTTCAAAATTTTGGAACTTATGTCCGAGAGACTTTGTACCC
AAAGGAATAGGTAACAGGGATCAACAGATTGGTTATTGGAATAGACAAACTCGCTAT
CGCATGGTGAAGGGCCAACGTAAAGAGCTTCCTGAAAGGTGGTTCTTCTACTACTTA
GGTACTGGACCTCATGCAGATGCCAAATTTAAAGATAAATTAGATGGAGTTGTCTGG
GTTGCCAAGGATGGCGCCATGAACAAACCAACCACGCTTGGTAGTCGTGGTGCTAAT
AATGAATCCAAAGCTTTGAAATTCGATGG?TAAAGTGCCAGGCGAATTTCAACTTGAA
GTTAATCAATCAAGAGACAATTCAAGGTCACGCTCTCAATCTAGATCTCGGTCTAGA
AATAGATCTCAATCTAGAGGCAGGCAACAATTCAATAACAAGAAGGATGACAGTGTA
GAACAAGCTGTTCTTGCCGCACTTAAAAAGTTAGGTGTTGACACAGAAAAACAACA
GCAACGCTCTCGTTCTAAATCTAAAGAACGTAGTAACTCTAAGACAAGAGATACTACA
CCTAAGAATGAAAACAAACACACCTGGAAGAGAACTGCAGGTAAAGGTGATGTGAC
AAGATTTTATGGAGCTAGAAGCAGTTCAGCCAATTTTGGTGACACTGACCTCGTTGC
CAATGGGAGCAGTGCCAAGCATTACCCACAACTGGCTGAATGTGTTCCATCTGTGTC
TAGCATCTGTTTGGAAGCTATTGGACTTCAAAGGAAGATGGCGACCAGATAGAAGT
CACGTTCACACACAAATACCACTTGCCAAAGGATGATCCTAAGACTGGACAATTCCT
TCAGCAGATTAATGCCTATGCTCGTCCATCAGAAGTGGCAAAAGAACAGAGAAAAAG
AAAATCTCGTTCTAAATCTGCAGAAAGGTCAGAGCAAGATGTGGTACCTGATGCATT
AATAGAAAATTATACAGATGTGTTTGATGACACACAGGTTGAGATGATTGACGAGGT
AACGAAC

Claims (3)

1, a kind of swine infectious enterogastritis recombinant N protein antigen, it is characterized in that: it is to carry out viral nucleic acid the TGEV virus liquid behind purifying to extract, upstream primer Li01 with TGEV N gene carries out the synthetic of viral genome cDNA, re-use the upstream and downstream primer of TGEV N gene, carry out the amplification of N gene, TGEV N gene clone after the amplification in prokaryotic expression carrier plasmid pProEXHTb, and is expressed the swine infectious enterogastritis recombinant N protein antigen that obtains in e.colistraindh5.
2, swine infectious enterogastritis recombinant N protein antigen according to claim 1, it is characterized in that: gene order is:
Figure A2005100097060002C1
GCCAACCAGGGACAGCGTATTAGTTGGGGGGATGA ATCTACCAAAACACGTGGTCGTTCCAATTCCCGTGGTCGGAAGAATAATAACATACCTCTTTCATTCTTCAACCCCATAACCCTCCAACAAGGTTCAAAATTTTGGAACTTATGTCCGAGAGACTTTGTACCCAAAGGAATAGGTAACAGGGATCAACAGATTGGTTATTGGAATAGACAAACTCGCTATCGCATGGTGAAGGGCCAACGTAAAGAGCTTCCTGAAAGGTGGTTCTTCTACTACTTAGGTACTGGACCTCATGCAGATGCCAAATTTAAAGATAAATTAGATGGAGTTGTCTGGGTTGCCAAGGATGGCGCCATGAACAAACCAACCACGCTTGGTAGTCGTGGTGCTAATAATGAATCCAAAGCTTTGAAATTCGATGGTAAAGTGCCAGGCGAATTTCAACTTGAAGTTAATCAATCAAGAGACAATTCAAGGTCACGCTCTCAATCTAGATCTCGGTCTAGAAATAGATCTCAATCTAGAGGCAGGCAACAATTCAATAACAAGAAGGATGACAGTGTAGAACAAGCTGTTCTTGCCGCACTTAAAAAGTTAGGTGTTGACACAGAAAAACAACAGCAACGCTCTCGTTCTAAATCTAAAGAACGTAGTAACTCTAAGACAAGAGATACTACACCTAAGAATGAAAACAAACACACCTGGAAGAGAACTGCAGGTAAAGGTGATGTGACAAGATTTTATGGAGCTAGAAGCAGTTCAGCCAATTTTGGTG ACACTGACCTCGTTGCCAATGGGAGCAGTGCCAAGCATTACCCACAACTGGCTGAATGTGTTCCATCTGTGTCTAGCATTCTGTTTGGAAGCTATTGGACTTCAAAGGAAGATGGCGACCAGATAGAAGTCACGTTCACACACAAATACCACTTGCCAAAGGATGATCCTAAGACTGGACAATTCCTTCAGCAGATTAATGCCTATGCTCGTCCATCAGAAGTGGCAAAAGAACAGAGAAAAAGAAAATCTCGTTCTAAATCTGCAGAAAGGTCAGAGCAAGATGTGGTACCTGATGCATTAATAGAAAATTATACAGATGTGTTTGATGACACACAGGTTGAGATGATTGACGAGGTAACGAAC
3, the antigenic method purifying of a kind of swine infectious enterogastritis recombinant N protein is characterized in that:
The great expression of 1 fusion rotein
(1) e.colistraindh5 of inoculating expressed fusion protein sways overnight incubation in 10ml LB/ penbritin liquid nutrient medium in 37 ℃;
(2) transfer the 10ml overnight culture in 500ml LB/ penbritin liquid nutrient medium, sway in 37 ℃ and be cultured to OD 590Value reaches about 0.5, takes out 1ml sample power supply swimming and analyzes;
(3) add 0.5ml 1mol/L IPTG to final concentration be 0.6mmol/L, continue to be cultured to OD value in 37 ℃ and reach 1.0, stop cultivating, take out 1ml sample power supply swimming analysis.
The purifying of 2 fusion roteins
(1) in 1.5cm * 7.5cm chromatography column, adds 1ml Ni 2+-NTA gel media behind the 20ml deionization washing post, is washed post with 20ml Buffer A solution again;
(2) with bacterium liquid through the centrifugal 20min of 10 000g/min, remove supernatant, sedimentary thalline carries out the cracking thalline with BufferA solution 10ml, dissolution precipitation, behind the stirring at room 1h, 4 ℃ continue to be stirred and to spend the night;
(3) solute is moved in the 30ml centrifuge tube, under 4 ℃ of conditions,, get supernatant and wait until upper prop usefulness with the centrifugal 40min of 20 000g/min;
(4) flow velocity of supernatant with 0.5ml/min joined in the Ni-NTA post; Collect effluent liquid, carry out SDS-PAGE and analyze;
(5) use 20ml Buffer A, the 20ml Buffer B flow velocity washing with 0.5ml/min successively, and collect effluent liquid, SDS-PAGE analyzes;
(6) wash with the Buffer C 10ml that contains the 80mmol/L imidazoles, collect elutriant, under the ultraviolet wavelength of 280nm, detect proteic absorption peak, preservation contains the elutriant of recombinant protein, and the storage temperature that short-term is preserved is 4 ℃, and the storage temperature of prolonged preservation is-20 ℃.
CN 200510009706 2005-02-04 2005-02-04 Recombinant N protein antigen and purification for transmissible gastroenteritis of swine Expired - Fee Related CN1285609C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200510009706 CN1285609C (en) 2005-02-04 2005-02-04 Recombinant N protein antigen and purification for transmissible gastroenteritis of swine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200510009706 CN1285609C (en) 2005-02-04 2005-02-04 Recombinant N protein antigen and purification for transmissible gastroenteritis of swine

Publications (2)

Publication Number Publication Date
CN1680433A true CN1680433A (en) 2005-10-12
CN1285609C CN1285609C (en) 2006-11-22

Family

ID=35067225

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200510009706 Expired - Fee Related CN1285609C (en) 2005-02-04 2005-02-04 Recombinant N protein antigen and purification for transmissible gastroenteritis of swine

Country Status (1)

Country Link
CN (1) CN1285609C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102660510A (en) * 2012-05-08 2012-09-12 北京大北农科技集团股份有限公司 Production method of porcine transmissible gastroenteritis virus by utilizing bioreactor

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102660510A (en) * 2012-05-08 2012-09-12 北京大北农科技集团股份有限公司 Production method of porcine transmissible gastroenteritis virus by utilizing bioreactor
CN102660510B (en) * 2012-05-08 2016-01-13 北京大北农科技集团股份有限公司 A kind of method utilizing bio-reactor to produce transmissible gastro-enteritis virus

Also Published As

Publication number Publication date
CN1285609C (en) 2006-11-22

Similar Documents

Publication Publication Date Title
Magbanua et al. White spot syndrome virus (WSSV) in cultured Penaeus monodon in the Philippines
RU2010100960A (en) VACCINES CONTAINING GENETIC OPTIONS OF DOG PARVIROVIRUS
CN107432930B (en) Group I4 avian adenovirus DNA vaccine and preparation method and application thereof
CN108823231A (en) A kind of 3 type genetic engineering subunit vaccine of pig circular ring virus and preparation method thereof
CN103820580B (en) Porcine circovirus 2 type LAMP diagnostic kit
CN108676917B (en) Dual nano PCR detection method for identifying CCoVI and CCoVII
Aydin et al. A pilot study on feline astrovirus and feline panleukopenia virus in shelter cats in Erzurum, Turkey
CN1285609C (en) Recombinant N protein antigen and purification for transmissible gastroenteritis of swine
CN1186459C (en) Mandarin fish infectious splenorenal necrosis virogene diagnostic kit and detecting method thereof
CN106754981A (en) A kind of method that utilization E. coli system prepares Goose Parvovirus sample particle
CN101058803A (en) Virus-like particles containing O-type foot-and-mouth disease virus IRES RNA, preparation method and application
CN105112561B (en) CH/GDDG/2014 plants of whole genome sequences of PPR virus and its amplimer pair
Hwang et al. Development of a nucleic acid detection method based on the CRISPR-Cas13 for point-of-care testing of bovine viral diarrhea virus-1b.
CN101054594A (en) Double-function fusion protein CBD-ProA carrier, immunity magnetic microsphere prepared from the same and application
CN1233843C (en) Kit of testing garlic virus and testing method
CN102839183A (en) Preparation method and application of recombinant enterovirus 71 type virus-like particle
CN105713994A (en) Method for synchronously detecting LSV (lily symptomless viruse) and LMoV (lily mottle viruse) with immuno-capture double RT-PCR (reverse transcription-polymerase chain reaction) techniques
CN111500784A (en) Primer group for differential diagnosis of different types of duck hepatitis viruses
CN113774162A (en) Novel coronavirus isothermal amplification primer, detection method and application
CN1563383A (en) Plamid vector, VP7 expresses antigen of blue tongue virus VP7 gene recombined expression, and preparation method
CN1811451A (en) Method for detecting nephrotic syndrome hemorrhagic fever antibody
CN1556216A (en) Detecting method of blue tongue virus and reagent box
CN1240847C (en) Reagent box for determining infectious chicken anemia
CN103409543B (en) Internal amplification control (IAC) multiple polymerase chain reaction (PCR) detection kit for bovine neosporosis and toxoplasmosis
CN116926065B (en) Nucleic acid extraction kit suitable for detecting pathogenic microorganisms and host residues and extraction method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
EE01 Entry into force of recordation of patent licensing contract

Assignee: Qingdao Boite Biopharmaceutical Co., Ltd.

Assignor: Northeast Agricultural University

Contract record no.: 2010990000439

Denomination of invention: Recombinant N protein antigen and purification for transmissible gastroenteritis of swine

Granted publication date: 20061122

License type: Exclusive License

Open date: 20051012

Record date: 20100624

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20061122

Termination date: 20130204